May 01, 2026 — RNews

#hematopoietic — Friday, May 01, 2026 (1 items)

hot top new

← prev day next day →

0

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial. (nature.com)

DiPersio JF … Cooper BW Nature Medicine 2026-05-01

#immunotherapy #crispr #genome editing #aml #hematopoietic